Orladeyo 150 mg – DIN 02527693
Orladeyo is Berotralstat Hydrochloride 150 mg (capsule), sold in Canada. It is supplied by Biocryst Pharmaceuticals Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Berotralstat Hydrochloride 150 mg
- Brand
- Orladeyo
- Strength
- 150 mg
- Form
- Capsule
- Manufacturer
- Biocryst Pharmaceuticals Inc
- Drug class
- Plasma kallikrein inhibitor
- Sold in
- Canada
- DIN
- 02527693
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Berotralstat Hydrochloride used for?
Berotralstat Hydrochloride is a plasma kallikrein inhibitor.
- Medicine type
- Plasma kallikrein inhibitor
Official uses from the US prescribing label
ORLADEYO® is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 2 years of age and older.
Limitations of Use:
The safety and effectiveness of ORLADEYO for the treatment of acute HAE attacks have not been established. ORLADEYO should not be used for treatment of acute HAE attacks. Additional doses or doses of ORLADEYO higher than the prescribed once-daily dose are not recommended due to the potential for QTc interval prolongation.
From the FDA-approved label on DailyMed (published Aug 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02527693.
- It names Orladeyo, Berotralstat Hydrochloride 150 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Orladeyo by Biocryst Pharmaceuticals Inc.
In Canada: prescription only.
Ingredients
Active: Berotralstat (Berotralstat Hydrochloride)